Does BOSUTINIB Cause Neoplasm progression? 376 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 376 reports of Neoplasm progression have been filed in association with BOSUTINIB (BOSULIF). This represents 4.8% of all adverse event reports for BOSUTINIB.
376
Reports of Neoplasm progression with BOSUTINIB
4.8%
of all BOSUTINIB reports
34
Deaths
44
Hospitalizations
How Dangerous Is Neoplasm progression From BOSUTINIB?
Of the 376 reports, 34 (9.0%) resulted in death, 44 (11.7%) required hospitalization, and 3 (0.8%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOSUTINIB. However, 376 reports have been filed with the FAERS database.
What Other Side Effects Does BOSUTINIB Cause?
Diarrhoea (1,820)
Nausea (886)
Fatigue (626)
Vomiting (469)
Death (465)
Rash (426)
Pleural effusion (398)
Dyspnoea (319)
Headache (283)
Drug intolerance (277)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which BOSUTINIB Alternatives Have Lower Neoplasm progression Risk?
BOSUTINIB vs BOTOX
BOSUTINIB vs BOTOX COSMETIC
BOSUTINIB vs BOTULINUM TOXIN NOS
BOSUTINIB vs BOTULINUM TOXIN TYPE A
BOSUTINIB vs BREMELANOTIDE